Proteolysis Targeting Chimeras - PROTACs

A new and promising therapeutic method in drug discovery

Targeted protein degradation using Proteolysis Targeting Chimeras, or PROTAC, is a new and promising therapeutic method in drug discovery. PROTACs have the ability to regulate protein degradation through targeted control of ubiquitin E3 ligases. This novel technology allows for the degradation of disease-related proteins and offers many advantages over traditional protein inhibition.

Our new range of critical enzymes, small molecular inhibitors, and homogeneous proximity assay services give you the power to research targeting protein degradation using PROTACs.

Homogeneous Proximity Assays

We offer a homogeneous proximity assay service to assess the chemical adaptor function of PROTACs. If you are interested in this service, contact us for more information.